Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma

This study has suspended participant recruitment.
(CRM: 31684 - CTEP PIO requested)
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Children's Oncology Group Identifier:
First received: January 6, 2013
Last updated: May 1, 2015
Last verified: May 2015
No Study Results Posted on for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: October 2018
  Primary Completion Date: October 2014 (Final data collection date for primary outcome measure)